BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19958851)

  • 1. An update on dual-energy x-ray absorptiometry.
    Blake GM; Fogelman I
    Semin Nucl Med; 2010 Jan; 40(1):62-73. PubMed ID: 19958851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of DXA bone density scans in the diagnosis and treatment of osteoporosis.
    Blake GM; Fogelman I
    Postgrad Med J; 2007 Aug; 83(982):509-17. PubMed ID: 17675543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical role of dual energy X-ray absorptiometry.
    Blake GM; Fogelman I
    Eur J Radiol; 2009 Sep; 71(3):406-14. PubMed ID: 19647962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The usefulness of dual energy X-ray and laser absorptiometry of the calcaneus versus dual energy X-ray absorptiometry of hip and spine in diagnosing manifest osteoporosis.
    de Klerk G; van der Velde D; van der Palen J; van Bergeijk L; Hegeman JH
    Arch Orthop Trauma Surg; 2009 Feb; 129(2):251-7. PubMed ID: 18825395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of dual-energy X-ray absorptiometry in the diagnosis and treatment of osteoporosis.
    Blake GM; Fogelman I
    J Clin Densitom; 2007; 10(1):102-10. PubMed ID: 17289532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical applications of bone density testing for osteoporosis.
    Lewiecki EM
    Minerva Med; 2005 Oct; 96(5):317-30. PubMed ID: 16227947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral density evaluation in osteoporosis: why yes and why not?
    Celi M; Rao C; Scialdoni A; Tempesta V; Gasbarra E; Pistillo P; Tarantino U
    Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S47-9. PubMed ID: 24046042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
    Siris ES; Baim S; Nattiv A
    Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative ability of dual-energy X-ray absorptiometry site selection in identifying patients with osteoporotic fractures.
    Arabi A; Baddoura R; Awada H; Khoury N; Haddad S; Ayoub G; El-Hajj Fuleihan G
    Bone; 2007 Apr; 40(4):1060-5. PubMed ID: 17223616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bone mineral density in postmenopausal women with proximal femoral fractures--comparative study between quantitative ultrasonometry and gold standard DXA].
    Schnabel M; Eser G; Ziller V; Mann D; Mann E; Hadji P
    Zentralbl Chir; 2005 Oct; 130(5):469-75. PubMed ID: 16220445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low bone mineral density and fracture burden in postmenopausal women.
    Cranney A; Jamal SA; Tsang JF; Josse RG; Leslie WD
    CMAJ; 2007 Sep; 177(6):575-80. PubMed ID: 17846439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posterior-anterior and lateral dual-energy x-ray absorptiometry for the assessment of vertebral osteoporosis and bone loss among older men.
    Zmuda JM; Cauley JA; Glynn NW; Finkelstein JS
    J Bone Miner Res; 2000 Jul; 15(7):1417-24. PubMed ID: 10893693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpretation of calcaneus dual-energy X-ray absorptiometry measurements in the assessment of osteopenia and fracture risk.
    Wren TA; Yerby SA; Beaupré GS; Carter DR
    J Bone Miner Res; 2000 Aug; 15(8):1573-8. PubMed ID: 10934656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of bone mechanical strenght and fracture risk assessment (Frax) in patients with hip joint replacement surgery.
    Rodrigues A; Caetano-Lopes J; Nery A; Sousa E; Polido-Pereira J; Vale M; Amaral P; Romeu JC; Viana Queiroz M; Monteiro J; Vaz MF; Fonseca JE; Canhão H
    Acta Reumatol Port; 2009; 34(3):504-10. PubMed ID: 19830928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction models for evaluation of total-body bone mass with dual-energy X-ray absorptiometry among children and adolescents.
    Horlick M; Wang J; Pierson RN; Thornton JC
    Pediatrics; 2004 Sep; 114(3):e337-45. PubMed ID: 15342895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of bone mineral density with dual x-ray absorptiometry for osteoporosis in children with bladder augmentation.
    Abeş M; Sarihan H; Madenci E
    J Pediatr Surg; 2003 Feb; 38(2):230-2. PubMed ID: 12596110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of the WHO fracture risk assessment tool (FRAX) to predict need for DEXA scanning and treatment in patients with inflammatory bowel disease at risk of osteoporosis.
    Goodhand JR; Kamperidis N; Nguyen H; Wahed M; Rampton DS
    Aliment Pharmacol Ther; 2011 Mar; 33(5):551-8. PubMed ID: 21198706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry.
    Cadarette SM; Jaglal SB; Kreiger N; McIsaac WJ; Darlington GA; Tu JV
    CMAJ; 2000 May; 162(9):1289-94. PubMed ID: 10813010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual energy x-ray absorptiometry and its clinical applications.
    Blake GM; Fogelman I
    Semin Musculoskelet Radiol; 2002 Sep; 6(3):207-18. PubMed ID: 12541198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fracture assessment tool risk scores in bone density reports do not change physician prescribing behavior for osteoporosis.
    Izuora KE; Alazraki N; Byrd-Sellers J; Tangpricha V; Nanes MS
    Am J Med Sci; 2011 Jul; 342(1):5-8. PubMed ID: 21412137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.